image
Healthcare - Biotechnology - NASDAQ - US
$ 5.08
-8.96 %
$ 750 M
Market Cap
-3.79
P/E
BALANCE SHEET
661 M ASSETS
-22.82%
353 M LIABILITIES
-10.10%
308 M EQUITY
-33.56%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Adaptive Biotechnologies Corporation
image
Current Assets 410 M
Cash & Short-Term Investments 346 M
Receivables 38 M
Other Current Assets 25.8 M
Non-Current Assets 251 M
Long-Term Investments 0
PP&E 120 M
Other Non-Current Assets 131 M
Current Liabilities 88 M
Accounts Payable 7.72 M
Short-Term Debt 18.8 M
Other Current Liabilities 61.5 M
Non-Current Liabilities 265 M
Long-Term Debt 220 M
Other Non-Current Liabilities 44.8 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017
ASSETS
Cash & Cash Equivalents 65.1 90.0 139.1 123.4 96.6 55.0 85.3
Short Term Investments 281.3 408.2 214.0 564.8 480.3 110.0 106.8
Receivables 38.0 40.1 17.4 10.0 12.7 4.8 5.6
Inventory 14.4 14.5 19.3 14.1 9.1 7.8 4.8
Other Current Assets 11.4 9.4 13.0 14.5 25.5 3.1 2.7
Total Current Assets 410.2 562.1 402.7 726.9 612.7 180.7 205.2
PP&E 120.3 164.2 172.9 139.0 60.4 19.1 14.0
Intangible Assets 5.1 6.8 8.5 10.2 11.9 13.6 15.3
Goodwill 119.0 119.0 119.0 119.0 119.0 119.0 119.0
Long Term Investments 0 2.4 217.1 118.5 105.4 0.2 8.9
Other Long Term Assets 6.5 4.5 3.0 2.7 2.9 0.2 86 K
Other Assets 0 0 0 0 0 0 0
Total Assets 661.1 856.6 923.3 1 116.4 912.3 332.7 362.5
LIABILITIES
Accounts Payable 7.7 8.1 3.3 3.2 4.5 1.8 2.0
Short Term Debt 18.8 18.5 10.1 7.1 0 0 0
Other Current Liabilities 12.8 18.9 19.5 19.8 12.9 8.3 5.0
Total Current Liabilities 88.0 109.8 113.8 105.2 78.3 22.8 21.0
Long Term Debt 220.0 98.8 106.7 104.3 36.6 561.2 0
Deferred Tax Income 0 0 (98.8) (163.6) 6.9 (561.2) 0
Other Liabilities 0 125.4 0 0 7.0 6.1 566.1
Total Liabilities 352.9 392.5 319.2 373.1 341.3 590.8 587.1
EQUITY
Common Stock 14 K 14 K 14 K 14 K 12 K 1 K 1 K
Retained Earnings (1 144.3) (919.1) (718.9) (511.6) (365.5) (295.9) (249.4)
Other Accumulative Comprehensive Income/Loss 0.2 (4.1) (1.1) 0.9 0.7 (0.1) (0.2)
Total Equity 308.3 464.1 604.1 743.3 571.0 (258.1) (224.6)
Total Liabilities and Equity 661.1 856.6 923.3 1 116.4 912.3 332.7 362.5
SHARES OUTSTANDING
Common Shares Outstanding 144.4 142.5 140.4 131.2 69.2 105.4 105.4